Home

Compare upto 3 Stocks

Add Companies

NECTAR LIFESCIENCES vs LINCOLN PHARMACEUTICALS vs GUJARAT THEMIS BIOSYN

Company
MARKETCAP
548 Cr.
619 Cr.
736 Cr.
ROBO ANALYTICS [LONG TERM]
Bad Fundamentals
Good Valuation
Debt : High
Average Fundamentals
Average Valuation
Debt : Low
Average Fundamentals
Bad Valuation
Debt : Low
ROBO ANALYTICS [SHORT TERM]
Upward Quarterly Trend
Mild Upward Momentum
High [>50%] Pledged Shares
Neutral Quarterly Trend
Mild Upward Momentum
None or < 25% Pledged Shares
Upward Quarterly Trend
Upward Momentum
None or < 25% Pledged Shares
SECTOR
Healthcare
Healthcare
Healthcare
INDUSTRY
Pharmaceuticals & Drugs
Pharmaceuticals & Drugs
Pharmaceuticals & Drugs
FUNDAMENTALS
VALUATION
FAIR/INTRINSIC VALUE
MOMENTUM
NECTAR LIFESCIENCES Analysis
LINCOLN PHARMACEUTICALS Analysis
GUJARAT THEMIS BIOSYN Analysis
Frequent Comparisons
Pharmaceuticals & Drugs Industry
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs GLAND PHARMA LTD

You may also like the below Video Courses


SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].